What if you could increase the operational efficiency of your studies while reducing the volume of wasted product, allowing for faster completion times and more reliable study results?
Gavin shares how using Speed to PatientTM supported cross-border drug supply during the COVID-19 pandemic.
Crystal talks about PCI's Speed to Patient offering and how it helped with a global orphan drug study.
The PCI WayTM - implementing Direct to Patient protocols: delivering life-changing therapies to those who need it most, anywhere in the world
“Accelerate your clinical trial distribution by leveraging PCI’s Speed to PatientTM solution.”
Director, Clinical Project Management
"Because patients are assured of potential time and cost-savings as well as additional conveniences when participating in Direct-to-Patient clinical trials versus traditional studies, use of the model has increased patient recruitment by up to 60 percent and helped maintain patient retention at over 95 percent."